- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Taiwanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
Lotus Pharmaceutical
Market Cap: NT$73.0b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$277.50
7D
-6.7%
1Y
6.3%
PharmaEngine
Market Cap: NT$10.1b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$70.40
7D
-3.0%
1Y
-20.7%
Ever Supreme Bio Technology
Market Cap: NT$14.4b
Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells in Taiwan.
6712
NT$164.50
7D
-2.7%
1Y
4.3%
TTY Biopharm
Market Cap: NT$20.4b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$82.20
7D
-1.2%
1Y
12.3%